Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: GlobalData
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sangamo Biosciences Inc Issues FY 2013 Revenue Guidance In Line With Analysts' Estimates

Wednesday, 6 Feb 2013 04:02pm EST 

Sangamo Biosciences Inc announced that for fiscal 2013, it expects revenues to be in the range of $20 to $24 million. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $23 million for fiscal 2013. 

Company Quote

0.14 +1.00%
24 Dec 2014